Karyopharm Therapeutics
KPTI
#9487
Rank
A$80.8 M
Marketcap
$9.43
Share price
8.01%
Change (1 day)
460.73%
Change (1 year)

Earnings for Karyopharm Therapeutics (KPTI)

Earnings in 2024 (TTM): -A$60.69 Million

According to Karyopharm Therapeutics 's latest financial reports the company's current earnings are A$0.14 Billion. , an increase over its 2023 earnings that were of -A$0.19 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Karyopharm Therapeutics from 2013 to 2024

Annual earnings

Year Earnings Change
2024 -A$60.5 Million-67.26%
2023 -A$0.19 Billion-14.99%
2022 -A$0.22 Billion43.11%
2021 -A$0.16 Billion-42.09%
2020 -A$0.27 Billion-8.07%
2019 -A$0.29 Billion5.76%
2018 -A$0.27 Billion33.02%
2017 -A$0.21 Billion19.28%
2016 -A$0.18 Billion-7.4%
2015 -A$0.19 Billion55.96%
2014 -A$0.12 Billion123.21%
2013 -A$52.74 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
A$32.94 B-54,556.51%๐Ÿ‡บ๐Ÿ‡ธ USA
A$9.48 B-15,784.46%๐Ÿ‡บ๐Ÿ‡ธ USA
A$10.89 B-18,108.37%๐Ÿ‡บ๐Ÿ‡ธ USA
A$1.05 B-1,850.35%๐Ÿ‡บ๐Ÿ‡ธ USA